|
Pre-Index Continuous Variables
|
LABA or LAMATx
|
LABA and LAMA Tx
|
LABA, LAMA, and ICS Tx
|
Significant Pairwise Paired t-tests*
|
|---|
| |
(n = 523)
|
(n = 523)
|
(n = 523)
| |
|---|
| |
LS Mean (SE)
|
LS Mean (SE)
|
LS Mean (SE)
| |
|---|
|
Age
|
70.0
|
(9.4)
|
70.7
|
(9.4)
|
70.4
|
(9.3)
|
NONE
|
|
Rx comorbidity score
|
6.2
|
(2.6)
|
6.4
|
(2.8)
|
6.2
|
(2.6)
|
NONE
|
|
% Days COPD medication exposure
|
64.3
|
(32.3)
|
66.3
|
(33.8)
|
63.2
|
(32.8)
|
DvT
|
|
Average copay amount
|
12.9
|
(12.4)
|
13.9
|
(13.4)
|
14.0
|
(12.4)
|
NONE
|
|
Total COPD-related costs
|
1,895.9
|
(1914.5)
|
1,987.7
|
(2411.5)
|
1,973.1
|
(2216.6)
|
NONE
|
|
Number of hospital visits
|
0.2
|
(0.5)
|
0.2
|
(0.5)
|
0.2
|
(0.5)
|
NONE
|
|
Number of days in hospital
|
0.8
|
(2.5)
|
0.8
|
(2.3)
|
0.6
|
(2.3)
|
NONE
|
|
Number of emergency room visits
|
0.5
|
(1.1)
|
0.4
|
(1.0)
|
0.4
|
(0.8)
|
NONE
|
|
Number of outpatient visits
|
21.7
|
(16.8)
|
22.4
|
(16.7)
|
20.9
|
(18.8)
|
NONE
|
- *Pairwise paired t-tests for dependent measures were conducted and pairs resulting in a significant p-value are listed (M = LABA or LAMA, D = LABA and LAMA, T = LABA, LAMA, ICS, NONE = No sig dif). All variables were derived from the 12 month pre-period.
